Dha supplements market

DHA Supplements Market, by Source (Fish Oil, Algal Oil, Krill Oil, and Others), by Form (Liquid, Capsules, and Powder), by Application (Pharmaceutical, Dietary Supplements, Fortified Food and Beverages, and Others), by Distribution Channel (Pharmacy and Drug Stores, Grocery Stores, Dietary Supplement Stores, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Request Free Sample

Mar 2022
CMI4951
156 Pages
Excel & Pdf
Pharmaceutical

Summary

Docosahexaenoic acid (DHA) is one of the most essential omega-3 fatty acids. It is linked to the benefits such as improved heart health, better vision, and reduced inflammatory response. DHA is found in every cell of the body and plays a critical role in brain development during pregnancy and infancy. DHA is essential for the health of the skin, eyes, and brain. Because the body cannot produce enough DHA that is required, it must be obtained through diet.

The global DHA supplements market is estimated to be valued at US$ 1,385.8 million in 2021 and is expected to exhibit a CAGR of 7.0% during the forecast period (2021-2028).

Figure 1.Global DHA Supplements Market Share (%) in Terms of Value, by Source, 2021

Increasing product launches is expected to drive the market growth during the forecast period.

Increasing product launches are expected to drive the growth of the global DHA supplements market over the forecast period. For instance, in April 2017, Anlit, a company that produces high-quality dietary supplements, launched a high DHA+EPA Omega-3 supplement in a single, fish-shaped chew supplement for children and adults. This product offers a friendly and tasty alternative, with no unpleasant after-taste, making it a good healthy option for children.

DHA Supplements Market Report Coverage

Report Coverage	Details
Base Year:	2020	Market Size in 2021:	US$ 1,385.8 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2021 to 2028
Forecast Period 2021 to 2028 CAGR:	7.0%	2028 Value Projection:	US$ 2,237.9 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Source: Fish Oil, Algal Oil, Krill Oil, Others By Form: Liquid, Capsules, Powder By Application: Pharmaceutical, Dietary Supplements, Fortified Food and Beverages, Others By Distribution Channel: Pharmacy and Drug Stores, Grocery Stores, Dietary Supplement Stores, Others
Companies covered:	BASF Corporation, DSM, Cellana Inc., JC Biotech Pvt.Ltd, FEMICO, Croda International Plc, Pharma Marine AS, Clover Corporation, Omega Protein Corporation, Kingdomway Nutrition, Inc., ECPlaza Network Inc., Bizen Chemical Co.LTD, Stepan Company, Novotech Nutraceuticals, Inc., Arjuna Natural, Jiangsu Auqi Marine Biotechnology Co., Ltd., and Aker BioMarine
Growth Drivers:	Rising demand of dietary supplements Increasing use of DHA supplements to maintain cardiovascular health, eye health, boost brain function, and others Increasing product launches
Restraints & Challenges:	High cost of DHA supplements Inconsistent universal guidelines

Figure 2.Global DHA Supplements Market Share (%), by Application, 2021

The increasing use of DHA supplements in treating cardiovascular diseases, brain disorders, and others is expected to drive the market growth during the forecast period.

The increased use of DHA supplements in treating various cardiovascular diseases, brain disorders, and others is expected to drive the market growth during the forecast period. For instance, according to an article published by Healthline Media, a provider of health information, in May 2019, DHA is extremely important for brain tissue growth and function, especially during infancy and development. The same source stated that low levels of DHA are linked with various diseases, including brain disorders such as Alzheimer’s disease. This article stated that patients with Alzheimer’s disease generally have lower amounts of DHA in their brains and livers.

Global DHA Supplements Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic brought attention to the importance and the potential benefits of dietary supplements, including DHA, in fighting the COVID-19 infection. For instance, according to an article published by the American Society for Microbiology in May 2021, preliminary evidence from banked blood samples of 100 COVID-19 patients suggests that patients with a higher omega-3 index, a measure of the amount of EPA and DHA in red blood cells, had a lower risk of death due to COVID-19. This study was carried out by the researchers of the Fatty Acid Research Institute (FARI), a non-profit research and education foundation, and collaborators at Cedars-Sinai Medical Center, a nonprofit academic healthcare organization, in Los Angeles and Orange County, California. The same source stated that considering that there is significant evidence that n-3 fatty acids and other fish oil-derived lipids possess anti-inflammatory properties and antithrombotic properties, they may have therapeutic value against the prothrombotic complications associated with COVID-19.

Therefore, the increasing research on the potential uses of DHA supplements in treating or reducing complications associated with viral infections such as COVID-19, and others, is expected to increase the demand for DHA supplements and thereby drive the global DHA supplements market growth over the forecast period.

Global DHA Supplements Market: Restraint

The major factors that hinder growth of the global DHA supplements market include the high cost of the DHA supplements and inconsistent universal guidelines. For instance, the article published by ScienceDirect, the world's leading source for scientific, technical, and medical research, in May 2020, stated that it is challenging to evaluate the compliance of dietary supplements products including DHA due to the lack of government regulations on oxidative quality specific to dietary supplements and content labeling requirements that are currently unclear.

Key Players

Major players operating in the global DHA supplements market include BASF Corporation, DSM, Cellana Inc., JC Biotech Pvt.Ltd, FEMICO, Croda International Plc, Pharma Marine AS, Clover Corporation, Omega Protein Corporation, Kingdomway Nutrition, Inc., ECPlaza Network Inc., Bizen Chemical Co.LTD, Stepan Company, Novotech Nutraceuticals, Inc., Arjuna Natural, Jiangsu Auqi Marine Biotechnology Co., Ltd., and Aker BioMarine.

Table of Content

*Browse 27 market data tables and 31 figures on "Global DHA Supplements Market” - forecast to 2028

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the market during the forecast period (2021-2028)?

The global DHA supplements market size is estimated to be valued at US$ 1,385.8 million in 2021 and is expected to exhibit a CAGR of 7.0% between 2021 and 2028.

What are the major factors driving the market growth?

Factors such as rising demand of dietary supplements, increasing use of DHA supplements to maintain cardiovascular health, eye health, boost brain function, and others, and increasing product launches are expected to drive the growth of the market during the forecast period.

Which is the leading source segment in the market?

Fish Oil segment is the leading source segment in the market.

What are the key factors hampering growth of the market?

The major factors hampering growth of the market include the high cost of DHA supplements and inconsistent universal guidelines.

Which are the major players operating in the market?

Major players operating in the market include BASF Corporation, DSM, Cellana Inc., JC Biotech Pvt.Ltd, FEMICO, Croda International Plc, Pharma Marine AS, Clover Corporation, Omega Protein Corporation, Kingdomway Nutrition, Inc., ECPlaza Network Inc., Bizen Chemical Co.LTD, Stepan Company, Novotech Nutraceuticals, Inc., Arjuna Natural, Jiangsu Auqi Marine Biotechnology Co., Ltd., and Aker BioMarine